ACADIA PHARMACEUTICALS INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $457.5M | $157.4M |
| Jun 2017 | — | $415.1M | $143.8M |
| Sep 2017 | — | $377.3M | $112.6M |
| Dec 2017 | — | $335.3M | $69.4M |
| Mar 2018 | — | $304.2M | $116.3M |
| Jun 2018 | — | $264.7M | $74.2M |
| Sep 2018 | — | $223.4M | $63.9M |
| Dec 2018 | — | $479.1M | $134.8M |
| Mar 2019 | — | $418.4M | $97.6M |
| Jun 2019 | — | $388.9M | $74.4M |
| Sep 2019 | — | $689.3M | $385.5M |
| Dec 2019 | — | $699.1M | $189.7M |
| Mar 2020 | — | $638.4M | $173.1M |
| Jun 2020 | — | $663.0M | $310.4M |
| Sep 2020 | — | $654.9M | $452.4M |
| Dec 2020 | — | $627.0M | $326.0M |
| Mar 2021 | — | $581.6M | $304.5M |
| Jun 2021 | — | $564.8M | $267.0M |
| Sep 2021 | — | $567.0M | $94.6M |
| Dec 2021 | — | $540.9M | $147.4M |
| Mar 2022 | — | $444.8M | $204.9M |
| Jun 2022 | — | $434.8M | $139.8M |
| Sep 2022 | — | $425.7M | $154.8M |
| Dec 2022 | — | $400.4M | $114.8M |
| Mar 2023 | — | $374.3M | $290.9M |
| Jun 2023 | — | $395.8M | $107.9M |
| Sep 2023 | — | $362.2M | $98.2M |
| Dec 2023 | — | $431.8M | $188.7M |
| Mar 2024 | — | $464.0M | $204.7M |
| Jun 2024 | — | $516.7M | $177.1M |
| Sep 2024 | — | $577.2M | $155.1M |
| Dec 2024 | — | $732.8M | $319.6M |
| Mar 2025 | — | $765.2M | $217.7M |
| Jun 2025 | — | $822.4M | $253.6M |
| Sep 2025 | — | $917.3M | $258.0M |
| Dec 2025 | — | $1.23B | $177.7M |
| Mar 2026 | — | $1.25B | $282.2M |
| Jun 2026 | — | $1.31B | $385.0M |